2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| ForUniqure B.V. | — | 4,376,883 | May 16, 2018 |
| Forbion 1 Management B.V. | — | 4,376,883 | May 16, 2018 |
| Kapusta Matthew C | CEO | 175,000 | Sep 26, 2025 |
| Dolmetsch Ricardo | President | 163,404 | Sep 20, 2023 |
| Zelenkofske Steven | Chief Medical Officer | 159,458 | Jun 8, 2018 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6, 2026 | Kapusta Matthew C | CEO | Sell | 90.0 | +56,019 | 9.26% | ✗ | $132.1K |
| Mar 4, 2026 | Mar 6, 2026 | Abi-Saab Walid | Chief Medical Officer | Sell | 90.0 | +40,892 | 27.49% | ✗ | $7.3K |
| Mar 4, 2026 | Mar 6, 2026 | Potts Jeannette | Chief Legal Officer | Sell | 91.3 | +31,988 | 30.04% | ✗ | $30.9K |
| Mar 4, 2026 | Mar 6, 2026 | KLEMT CHRISTIAN | CFO | Sell | 95.0 | +27,600 | 13.87% | ✗ | $108.7K |
| Mar 2, 2026 | Mar 4, 2026 | Kapusta Matthew C | CEO | Sell | 40.0 | -34,437 | -5.39% | ✗ | $342.6K |
| Mar 2, 2026 | Mar 4, 2026 | KLEMT CHRISTIAN | CFO | Sell | 42.5 | -12,532 | -5.92% | ✗ | $124.7K |
| Mar 2, 2026 | Mar 4, 2026 | Potts Jeannette | Chief Legal Officer | Sell | 42.5 | -8,578 | -7.45% | ✗ | $85.4K |
| Mar 2, 2026 | Mar 4, 2026 | Abi-Saab Walid | Chief Medical Officer | Sell | 46.3 | -1,660 | -1.10% | ✗ | $16.5K |
| Feb 25, 2026 | Feb 27, 2026 | Kapusta Matthew C | CEO | Sell | 40.0 | -12,378 | -1.90% | ✗ | $295.3K |
| Feb 25, 2026 | Feb 27, 2026 | KLEMT CHRISTIAN | CFO | Sell | 42.5 | -6,217 | -2.86% | ✗ | $148.3K |
| Jan 12, 2026 | Jan 14, 2026 | Gut Robert | Director | Sell | 10.0 | -25,613 | -44.19% | ✓ | $630.5K |
| Jan 9, 2026 | Jan 12, 2026 | Kaye Jack | Director | Sell | 16.3 | -6,390 | -23.82% | ✓ | $174.3K |
| Nov 6, 2025 | Nov 10, 2025 | Gut Robert | Director | Sell | 7.5 | -31,434 | -43.92% | ✓ | $856.9K |
| Nov 4, 2025 | Nov 6, 2025 | Kaye Jack | Director | Sell | 5.0 | -38,810 | -38.76% | ✓ | $1.2M |
| Sep 24, 2025 | Sep 26, 2025 | Kapusta Matthew C | CEO | Sell | 3.8 | -226,316 | -25.78% | ✓ | $9.4M |
| Sep 24, 2025 | Sep 26, 2025 | KLEMT CHRISTIAN | CFO | Sell | 35.0 | -18,000 | -3.97% | ✓ | $945.1K |
| Jun 27, 2025 | Jul 1, 2025 | Abi-Saab Walid | Chief Medical Officer | Sell | 48.8 | -1,466 | -0.97% | ✗ | $20.4K |
| Jun 20, 2025 | Jun 24, 2025 | Springhorn Jeremy P. | Director | Sell | 46.3 | -2,112 | -5.31% | ✗ | $30.5K |
| Jun 20, 2025 | Jun 24, 2025 | POST LEONARD E | Director | Sell | 46.3 | -2,112 | -6.59% | ✗ | $30.5K |
| Jun 20, 2025 | Jun 24, 2025 | Kaye Jack | Director | Sell | 46.3 | -2,112 | -9.37% | ✗ | $30.5K |
| Jun 20, 2025 | Jun 24, 2025 | Jacques Rachelle Suzanne | Director | Sell | 46.3 | -2,112 | -6.93% | ✗ | $30.5K |
| Jun 20, 2025 | Jun 24, 2025 | Gut Robert | Director | Sell | 46.3 | -3,336 | -5.54% | ✗ | $48.2K |
| Jun 20, 2025 | Jun 24, 2025 | Balachandran Madhavan | Director | Sell | 46.3 | -2,112 | -5.31% | ✗ | $30.5K |
| Jun 20, 2025 | Jun 24, 2025 | Meek David D. | Director | Sell | 46.3 | -2,112 | -5.82% | ✗ | $30.5K |
| Jun 16, 2025 | Jun 20, 2025 | Potts Jeannette | Chief Legal Officer | Sell | 42.5 | -4,670 | -3.90% | ✗ | $70.7K |
| Jun 11, 2025 | Jun 13, 2025 | POST LEONARD E | Director | Neutral | 90.0 | +7,970 | 33.10% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Kaye Jack | Director | Neutral | 90.0 | +7,970 | 54.66% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Jacques Rachelle Suzanne | Director | Neutral | 90.0 | +7,970 | 35.44% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Gut Robert | Director | Neutral | 90.0 | +7,970 | 15.26% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Balachandran Madhavan | Director | Neutral | 90.0 | +7,970 | 25.03% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Springhorn Jeremy P. | Director | Neutral | 90.0 | +7,970 | 25.03% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Meek David D. | Director | Neutral | 90.0 | +7,970 | 28.13% | ✗ | - |
| Mar 3, 2025 | Mar 5, 2025 | Kapusta Matthew C | CEO | Sell | 97.5 | +70,659 | 12.17% | ✗ | $291.6K |
| Mar 3, 2025 | Mar 5, 2025 | Abi-Saab Walid | Chief Medical Officer | Sell | 91.3 | +36,650 | 31.80% | ✗ | $13.9K |
| Mar 3, 2025 | Mar 5, 2025 | KLEMT CHRISTIAN | CFO | Sell | 95.0 | +62,562 | 40.32% | ✗ | $107.4K |
| Mar 3, 2025 | Mar 5, 2025 | Potts Jeannette | Chief Legal Officer | Sell | 95.0 | +27,924 | 30.41% | ✗ | $72.8K |
| Feb 25, 2025 | Feb 27, 2025 | Kapusta Matthew C | CEO | Sell | 40.0 | -17,120 | -2.86% | ✗ | $362K |
| Feb 25, 2025 | Feb 27, 2025 | KLEMT CHRISTIAN | CFO | Sell | 42.5 | -11,545 | -6.93% | ✗ | $186.5K |
| Dec 10, 2024 | Dec 12, 2024 | Kapusta Matthew C | CEO | Sell | 20.0 | -100,000 | -14.33% | ✓ | $1.5M |
| Dec 8, 2024 | Dec 10, 2024 | Kapusta Matthew C | CEO | Sell | 78.8 | +7,076 | 1.20% | ✗ | $26.1K |
| Dec 8, 2024 | Dec 10, 2024 | KLEMT CHRISTIAN | CFO | Sell | 78.8 | +1,876 | 1.14% | ✗ | $13.6K |
| Jun 26, 2024 | Jun 28, 2024 | Abi-Saab Walid | Chief Medical Officer | Sell | 47.5 | -1,447 | -1.24% | ✗ | $6.3K |
| Jun 19, 2024 | Jun 21, 2024 | Gut Robert | Director | Neutral | 90.0 | +8,080 | 18.30% | ✗ | - |
| Jun 19, 2024 | Jun 21, 2024 | Springhorn Jeremy P. | Director | Neutral | 90.0 | +8,080 | 34.01% | ✗ | - |
| Jun 19, 2024 | Jun 21, 2024 | Meek David D. | Director | Neutral | 90.0 | +8,080 | 39.90% | ✗ | - |
| Jun 19, 2024 | Jun 21, 2024 | Balachandran Madhavan | Director | Neutral | 90.0 | +8,080 | 34.01% | ✗ | - |
| Jun 19, 2024 | Jun 21, 2024 | Kaye Jack | Director | Neutral | 90.0 | +8,080 | 124.29% | ✗ | - |
| Jun 19, 2024 | Jun 21, 2024 | POST LEONARD E | Director | Neutral | 90.0 | +8,080 | 50.50% | ✗ | - |
| Jun 19, 2024 | Jun 21, 2024 | Jacques Rachelle Suzanne | Director | Neutral | 90.0 | +8,080 | 56.08% | ✗ | - |
| Jun 17, 2024 | Jun 20, 2024 | CALOZ PIERRE | COO | Sell | 46.3 | -2,936 | -2.47% | ✗ | $14.1K |
| Jun 17, 2024 | Jun 20, 2024 | KLEMT CHRISTIAN | CFO | Sell | 50.0 | -1,611 | -0.97% | ✗ | $7.7K |
| Jun 13, 2024 | Jun 18, 2024 | POST LEONARD E | Director | Sell | 46.3 | -2,222 | -12.19% | ✗ | $11.4K |
| Jun 13, 2024 | Jun 17, 2024 | Potts Jeannette | Chief Legal Officer | Sell | 46.3 | -4,781 | -4.95% | ✗ | $23.8K |
| Jun 13, 2024 | Jun 17, 2024 | Springhorn Jeremy P. | Director | Sell | 46.3 | -2,231 | -8.59% | ✗ | $11.4K |
| Jun 13, 2024 | Jun 17, 2024 | Meek David D. | Director | Sell | 46.3 | -2,229 | -9.92% | ✗ | $11.4K |
| Jun 13, 2024 | Jun 17, 2024 | Balachandran Madhavan | Director | Sell | 46.3 | -2,231 | -8.58% | ✗ | $11.4K |
| Jun 13, 2024 | Jun 17, 2024 | Soteropoulos Paula | Director | Sell | 46.3 | -2,220 | -9.90% | ✗ | $11.4K |
| Jun 13, 2024 | Jun 17, 2024 | Gut Robert | Director | Sell | 46.3 | -3,504 | -7.35% | ✗ | $17.9K |
| Jun 13, 2024 | Jun 17, 2024 | Kaye Jack | Director | Sell | 46.3 | -2,218 | -25.44% | ✗ | $11.4K |
| Jun 13, 2024 | Jun 17, 2024 | Jacques Rachelle Suzanne | Director | Sell | 46.3 | -2,221 | -13.36% | ✗ | $11.4K |
| Mar 1, 2024 | Mar 5, 2024 | Kapusta Matthew C | CEO | Neutral | 90.0 | +150,000 | 34.03% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | KLEMT CHRISTIAN | CFO | Neutral | 90.0 | +49,500 | 42.33% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | Abi-Saab Walid | Chief Medical Officer | Neutral | 90.0 | +49,500 | 73.66% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | CALOZ PIERRE | COO | Neutral | 90.0 | +33,000 | 38.53% | ✗ | - |
| Mar 1, 2024 | Mar 5, 2024 | Potts Jeannette | Chief Legal Officer | Neutral | 90.0 | +49,500 | 105.10% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | CALOZ PIERRE | COO | Sell | 42.5 | -9,455 | -9.94% | ✗ | $61.2K |
| Feb 26, 2024 | Feb 28, 2024 | KLEMT CHRISTIAN | CFO | Sell | 42.5 | -15,906 | -11.97% | ✗ | $101.5K |
| Feb 26, 2024 | Feb 28, 2024 | Kapusta Matthew C | CEO | Sell | 42.5 | -27,904 | -5.95% | ✗ | $177.2K |
| Jun 23, 2023 | Feb 6, 2024 | Kaye Jack | Director | Neutral | 27.5 | -25,400 | -74.45% | ✗ | - |
| Oct 2, 2023 | Abi-Saab Walid | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 18, 2023 | Sep 20, 2023 | Dolmetsch Ricardo | President | Sell | 46.3 | -5,841 | -3.45% | ✗ | $43.6K |
| Jul 10, 2023 | Jul 12, 2023 | CALOZ PIERRE | COO | Sell | 25.0 | -15,117 | -13.72% | ✓ | $171.7K |
| Jun 13, 2023 | Jun 20, 2023 | Jacques Rachelle Suzanne | Director | Sell | 91.3 | +6,399 | 62.55% | ✗ | $43.2K |
| Jun 13, 2023 | Jun 20, 2023 | Soteropoulos Paula | Director | Sell | 91.3 | +6,425 | 40.16% | ✗ | $43.2K |
| Jun 13, 2023 | Jun 20, 2023 | POST LEONARD E | Director | Sell | 91.3 | +6,409 | 54.26% | ✗ | $43.1K |
| Jun 13, 2023 | Jun 20, 2023 | Meek David D. | Director | Sell | 91.3 | +6,410 | 39.89% | ✗ | $43.2K |
| Jun 13, 2023 | Jun 20, 2023 | Kaye Jack | Director | Sell | 91.3 | +6,420 | 23.18% | ✗ | $43.2K |
| Jun 13, 2023 | Jun 20, 2023 | Gut Robert | Director | Sell | 95.0 | +5,472 | 12.97% | ✗ | $60.9K |
| Jun 13, 2023 | Jun 20, 2023 | Balachandran Madhavan | Director | Sell | 91.3 | +6,417 | 32.78% | ✗ | $43.2K |
| Jun 16, 2023 | Jun 20, 2023 | CALOZ PIERRE | COO | Sell | 42.5 | -2,920 | -2.58% | ✗ | $54.9K |
| Jun 16, 2023 | Jun 20, 2023 | KLEMT CHRISTIAN | CFO | Sell | 46.3 | -1,587 | -1.18% | ✗ | $30.1K |
| Jun 13, 2023 | Jun 20, 2023 | Springhorn Jeremy P. | Director | Sell | 91.3 | +6,414 | 32.77% | ✗ | $43.2K |
| Jun 13, 2023 | Jun 15, 2023 | Potts Jeannette | Officer | Neutral | 90.0 | +47,100 | 100.00% | ✗ | - |
| Jun 15, 2023 | Potts Jeannette | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 7, 2023 | Mar 9, 2023 | CALOZ PIERRE | COO | Sell | 48.8 | -990 | -0.87% | ✗ | $21.1K |
| Mar 7, 2023 | Mar 9, 2023 | Kuta Alexander Edward III | Executive VP, Operations | Sell | 48.8 | -585 | -0.64% | ✗ | $12.5K |
| Mar 7, 2023 | Mar 9, 2023 | KLEMT CHRISTIAN | CFO | Sell | 48.8 | -986 | -0.73% | ✗ | $21.1K |
| Mar 7, 2023 | Mar 9, 2023 | Dolmetsch Ricardo | President | Sell | 51.3 | -837 | -0.49% | ✗ | $17.6K |
| Mar 7, 2023 | Mar 9, 2023 | Kapusta Matthew C | CEO | Sell | 45.0 | -2,521 | -0.53% | ✗ | $53.9K |
| Feb 27, 2023 | Mar 1, 2023 | POST LEONARD E | Director | Sell | 47.5 | -389 | -3.19% | ✗ | $7.7K |
| Feb 27, 2023 | Mar 1, 2023 | Kuta Alexander Edward III | Executive VP, Operations | Sell | 42.5 | -6,726 | -6.88% | ✗ | $135.7K |
| Feb 27, 2023 | Mar 1, 2023 | Balachandran Madhavan | Director | Sell | 47.5 | -384 | -1.92% | ✗ | $7.7K |
| Feb 27, 2023 | Mar 1, 2023 | Soteropoulos Paula | Director | Sell | 47.5 | -384 | -2.34% | ✗ | $7.7K |
| Feb 27, 2023 | Mar 1, 2023 | CALOZ PIERRE | COO | Sell | 42.5 | -4,365 | -3.68% | ✗ | $85.6K |
| Feb 27, 2023 | Mar 1, 2023 | KLEMT CHRISTIAN | CFO | Sell | 42.5 | -11,193 | -7.63% | ✗ | $226.1K |
| Feb 27, 2023 | Mar 1, 2023 | Dolmetsch Ricardo | President | Sell | 42.5 | -6,944 | -3.92% | ✗ | $136K |
| Feb 27, 2023 | Mar 1, 2023 | Kapusta Matthew C | CEO | Sell | 40.0 | -24,547 | -4.95% | ✗ | $493.3K |
| Feb 27, 2023 | Mar 1, 2023 | Springhorn Jeremy P. | Director | Sell | 47.5 | -384 | -1.92% | ✗ | $7.8K |
| Feb 27, 2023 | Mar 1, 2023 | Jacques Rachelle Suzanne | Director | Sell | 47.5 | -384 | -3.62% | ✗ | $7.7K |
| Feb 27, 2023 | Mar 1, 2023 | Kaye Jack | Director | Sell | 47.5 | -384 | -1.37% | ✗ | $7.7K |